Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutations

被引：0

作者：

Roberto Ruiz-Cordero

Junsheng Ma

Abha Khanna

Genevieve Lyons

Waree Rinsurongkawong

Roland Bassett

Ming Guo

Mark J. Routbort

Jianjun Zhang

Ferdinandos Skoulidis

John Heymach

Emily B. Roarty

Zhenya Tang

L. Jeffrey Medeiros

Keyur P. Patel

Rajyalakshmi Luthra

Sinchita Roy-Chowdhuri

机构：

[1] University of California San Francisco,Department of Pathology

[2] The University of Texas MD Anderson Cancer Center,Department of Thoracic/Head and Neck Medical Oncology

[3] The University of Texas MD Anderson Cancer Center,Department of Hematopathology

[4] The University of Texas MD Anderson Cancer Center,Department of Biostatistics

[5] The University of Texas MD Anderson Cancer Center,Department of Pathology

来源：

BMC Cancer | / 20卷

关键词：

Lung adenocarcinoma; Next generation sequencing; Molecular subtypes;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutations
Ruiz-Cordero, Roberto
Ma, Junsheng
Khanna, Abha
Lyons, Genevieve
Rinsurongkawong, Waree
Bassett, Roland
Guo, Ming
Routbort, Mark J.
Zhang, Jianjun
Skoulidis, Ferdinandos
Heymach, John
Roarty, Emily B.
Tang, Zhenya
Medeiros, L. Jeffrey
Patel, Keyur P.
Luthra, Rajyalakshmi
Roy-Chowdhuri, Sinchita
[J]. BMC CANCER, 2020, 20 (01)
[2] The Prognostic Impact of EGFR, KRAS and TP53 Somatic Mutations in Curatively Resected Early-Stage Lung Adenocarcinomas
Rothberg, Bonnie Gould
Das, Rahul
Jackson, Laura
Lazowski, Heather
Bai, Yalai
O'Neill, Daniel
Roberts, Sophia
Rothberg, Jonathan
Herbst, Roy
Kim, Anthony
Boffa, Daniel
Rimm, David
Detterbeck, Frank
Tanoue, Lynn
[J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S623 - S624
[3] KRAS/LKB1 and KRAS/TP53 co-mutations create divergent immune signatures in lung adenocarcinomas
Gu, Meichen
Xu, Tiankai
Chang, Pengyu
[J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
[4] Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer: the EUELC cohort
Scoccianti, Chiara
Vesin, Aurelien
Martel, Ghislaine
Olivier, Magali
Brambilla, Elisabeth
Timsit, Jean-Francois
Tavecchio, Luca
Brambilla, Christian
Field, John K.
Hainaut, Pierre
[J]. EUROPEAN RESPIRATORY JOURNAL, 2012, 40 (01) : 177 - 184
[5] EGFR and KRAS mutations in metastatic Lung adenocarcinomas
Munfus-McCray, Delicia
Harada, Shuko
Adams, Christina
Askin, Frederic
Clark, Douglas
Gabrielson, Edward
Li, Qing Kay
[J]. HUMAN PATHOLOGY, 2011, 42 (10) : 1447 - 1453
[6] KRAS, KIT and TP53 mutations in mother's and daughter's gastric cardia adenocarcinomas
Gluszek, Stanislaw
Koziel, Dorota
Kowalik, Artur
Zieba, Sebastian
Urbaniak-Wasik, Slawka
Wincewicz, Andrzej
Sulkowski, Stanislaw
[J]. GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY, 2018, 13 (01): : 76 - 79
[7] Prognostic value of KRAS mutations, TP53 mutations and PD-L1 expression among lung adenocarcinomas treated with immunotherapy
Tonnesen, Ea Maria Tonning
Stougaard, Magnus
Meldgaard, Peter
Lade-Keller, Johanne
[J]. JOURNAL OF CLINICAL PATHOLOGY, 2024, 77 (01) : 54 - 60
[8] Mutation of TP53 and Alteration of p14arf Expression in EGFR- and KRAS-Mutated Lung Adenocarcinomas
Cortot, Alexis B.
Younes, Mohamad
Martel-Planche, Ghislaine
Guibert, Benoit
Isaac, Sylvie
Souquet, Pierre-Jean
Commo, Frederic
Girard, Philippe
Fouret, Pierre
Brambilla, Elisabeth
Hainaut, Pierre
Soria, Jean-Charles
[J]. CLINICAL LUNG CANCER, 2014, 15 (02) : 124 - 130
[9] PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers
Jin, Guang
Kim, Min Jung
Jeon, Hyo-Sung
Choi, Jin Eun
Kim, Dong Sun
Lee, Eung Bae
Cha, Sung Ick
Yoon, Ghil Sook
Kim, Chang Ho
Jung, Tae Hoon
Park, Jae Yong
[J]. LUNG CANCER, 2010, 69 (03) : 279 - 283
[10] Differential responses to therapy in Hispanic NSCLC patients with EGFR, KRAS, or TP53 mutations.
Basher, Fahmin
Saravia, Diana
Lopes, Gilberto
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)

← 1 2 3 4 5 →